DatasetName,NMT1_S(43) NMT1_S(46) NMT1_S(47) NMT1_T(117) NMT1_T(52),NMT1_S(31) NMT1_S(4) NMT1_S(69) NMT1_S(73) NMT1_S(83) NMT1_T(71),NMT1_S(100)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,0.5570069591639483,,
FSO2013_Ratio M/L normalized Rep3,0.5837871180770327,0.4897366019804575,
SR2019_MCF7_Biol_repl_3,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,0.6042009547384124,,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,,,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,0.5885684931077317,0.45897774074503844,
HS2024_6_B_T3,0.5651735937826862,,
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,0.5991082817804142,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,0.5876646875981202,0.42953651362335604,
SR2019_MDAMB231_Biol_repl_4,,,
GF2025_P2_Sph,,0.4812520301092332,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,0.6001450792349122,,
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,0.5726502872753206,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,0.5808111851726019,0.47969811390629213,
FSO2013_Ratio M/L normalized Rep1___1,0.5875593282858874,0.42987047347227625,
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,,,
RB2022_5_PreEndurance,0.543303970002958,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,0.5744855513438221,0.5015508732544328,
WZ2023_Pu_010_30min,0.6244059972181999,0.4415913296952742,
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,0.550513608864368,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,,,
RB2022_8_RecoveryEndurance,0.600748425906134,,
KBE2022_Log2_Ex_14_U,0.6018295301043148,,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,,,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,,,
RB2022_5_PreSprint,0.5373162382071242,,
PG2020_Intensity 8h_C,,,
AH2018_SILAC_MR_2_N,,0.4759859668420316,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,0.5935800676405958,,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,0.5886330414415661,,
FSO2013_Ratio H/L normalized Rep2___2,,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5695765816520785,0.48329180182176773,
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,0.5960848298557305,,
GF2025_P6_Sph,,0.4727955553534556,
RB2022_2_PreSprint,,,
ZX2022_CB treated Replicate 3,0.5850280293094211,0.4605360867718135,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,0.6245088298861392,0.42291467332032157,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,0.57291667234998,,
KBE2022_Log2_Ex_34_U,0.6142190646279955,,
WZ2023_Pu_005_10min,0.6235998558806347,0.4392740669318033,
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,0.6084166865554121,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,0.6224107680938941,0.4430771565627693,
AH2018_SILAC_MR_2_X,,0.42546310542522137,
HS2024_4_PD_T2,0.590918966752445,0.5075590187140484,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,,,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,0.56423610906649,0.4777021133912082,
FR2021_Norm.Intensity.B,0.5575936351417454,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,,,
EJN2021_3_Rest_Basal,0.6031790009521302,,
CR2017_Ratio Replicate 1.3,0.5816410387480492,0.42159279442150294,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,,,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,,0.4712018384039942,
HS2024_7_PD_T2,0.5847259149239086,0.4774378045970196,
FSO2013_Ratio H/L normalized Rep1___1,0.5925018152419066,0.41945537138927097,
AH2018_LFQ_1_C,,0.4459255561320174,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,0.6146047919543,,
HS2024_3_B_N1,0.5797640869881959,,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,0.6240183684455747,0.42155545456119575,
CK2022_11 40-1,0.6088249950599127,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,,0.46731813686366735,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,,0.468391389234111,
FSO2013_Ratio H/L normalized Rep2,0.585943506064664,0.4475925142868759,
WZ2023_Pu_005_20min,0.6251861424376134,0.4309138518226374,
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,0.5811964608836091,0.4603206058353498,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,0.5483843407520891,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,,0.4545118814197808,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,,,
HS2024_9_B_T2,0.6012498061259235,,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,0.574596564524355,0.45646384673676027,
FSO2013_Ratio M/L normalized Rep3___2,,,
SR2019_BT549_Biol_repl_3,,,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,0.5776937396567501,,
RB2022_2_PreStrength,,,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,0.5797727626024514,0.47266775460135957,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,0.6086718567768934,,
CK2022_1 200-1,0.6315815894746727,0.4668739050125983,
PG2020_Intensity Mock_10h_D,0.5624971110160459,,
SR2019_MCF10A_Biol_repl_2,,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,0.5701889878507194,0.4892917021776821,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5701167265666038,0.46929237068330093,
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,0.5799204170644185,0.4297466401598456,
PG2020_Intensity 2h_C,,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,0.5826520807616322,0.4597470869066966,
KBE2022_Log2_Ex_8_T,0.6091394109472109,,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,0.5800494005012463,0.4861048432310018,
RN2012_L11,0.565058390944141,0.4787926850642461,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,0.5987062986980503,,
HS2024_5_PD_T1,0.5958754672807209,0.4393593991086769,
AH2018_LFQ_M_2_C,,0.4507700388055486,
CK2022_3 40-1,0.6150911621682148,,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,0.5798058290096348,,
YA2020_Reporter_intensity_Cancer_No.5,,,
HH2022_Reporter intensity 8,0.6098857097729529,,
ZQ2022_N2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,,,
EJN2021_5_Rest_Basal,0.6078409943376684,,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,0.5955664013396745,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,,,
YA2020_Reporter_intensity_Normal_No.1,,,
HS2024_3_B_T1,0.5694007941466352,0.4702985740952779,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,0.5360057636260362,,
RB2022_1_PostEndurance,,,
CR2017_Ratio Replicate 3,0.5905568442147398,0.4968742483414099,
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,0.5938870380146397,,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,,0.46819157937478534,
HS2024_8_I_T3,0.6165555979536579,0.4629968301095886,
CF2017_EOC 3,,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,0.5888337069871221,0.4874279794733005,
DL2023_12h-2,,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,0.6241932862480959,0.4190683124999918,
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,0.6142491707678245,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,0.6041046650708368,,
KS2014_Intensity N3,,0.44431143820922697,
RB2022_4_RecoveryEndurance,,,
RB2022_5_RecoveryEndurance,,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,,,
FSO2013_Ratio H/M normalized Rep2,0.5903033689700944,0.4354661382988933,
RAM2015_Log2 A,0.5880919473530174,,
HS2024_8_PD_T1,0.6087748214271813,0.45121703881916625,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,,,
KS2014_Intensity E15_2,,0.46490732885948627,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,,,
HS2024_7_I_T1,0.5457082587078224,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,0.5870124118808616,,
AH2018_SILAC_M_3_X,,,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,0.6077336232303315,,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,0.5554308867724801,,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,0.5706557828472546,,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,0.5763829679931038,0.5051138329348749,
HS2024_6_B_N1,0.5921512835422531,,
KBE2022_Log2_Ex_27_T,0.6112968533134334,0.46099286137960754,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.46331328037198305,
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,0.597527924038739,,
AH2018_SILAC_IT_3_X,,0.462553733361847,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,,,
FSO2013_Ratio M/L normalized Rep2,0.5981576052885551,0.41150133516341225,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,0.6217485657149318,,
SR2019_HCC1954_Biol_repl_2,,,
CK2022_14 40-1,0.6132088703969787,,
RB2022_6_PreSprint,,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,0.5664950223659592,,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,,,
DL2023_control-1,,,
AR2021_ALG 10 μM,0.5829474228726181,0.4480451231919503,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,,0.4746991724600716,
EJN2021_4_Rest_Ins,0.6020937781433063,,
RN2012_H05,0.5733816765504638,,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,,0.48628892034723564,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,,,
EJN2021_1_Rest_Ins,0.6098439231284016,,
HH2022_Reporter intensity 3,0.5640595015459793,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,,0.47644386525689314,
JW2021_After_3,,,
GF2025_P8_Sph,,0.47999530134526275,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,,0.47044866363594506,
CK2022_11 200-1,0.6310505185903876,0.47199742582415355,
CK2022_12 200-1,0.6334588617221584,0.4762299733299095,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,0.6116831959969111,,
WZ2023_Su_010_20min,0.6243334872422064,0.4377993955919441,
AH2018_TMTMS2_2_N,,,0.2608430495020414
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,0.6015632012708172,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.4775114670088132,
AH2018_TMTMS3_Pool,,,
KS2014_Intensity N4,,0.44820182883118975,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,,,
CK2022_14 200-1,0.6315082840039745,0.4601410960160135,
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,0.5488630122647293,,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,,,
AST2020_anti-CD3+PDL2.2,0.5733911446906401,,
PG2020_Intensity Mock_10h_A,0.5665058072698835,,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,0.6079773465478937,,
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,0.6087220347595729,,
GF2025_P1_Adh,,0.4883001059482954,
GF2025_P1_Sph,,0.47880915522335593,
EJN2021_5_Ex_Basal,0.6046843446819261,,
HS2024_7_I_T3,0.6196783605080683,0.490829446918671,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.6244568174223565,0.4243022998738705,
CF2017_EOC 1,,,
CK2022_3 200-1,0.6322745620422756,0.46639336868017733,
AH2018_LFQ_IT_3_C,,0.4662478266170906,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,0.5746756345117745,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,0.5958985102176726,0.478988746080855,
HS2024_5_B_T1,0.6278075708308324,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,,
SR2019_MDAMB231_Biol_repl_2,,,
HS2024_3_B_T2,0.5984997906999767,,
RB2022_6_PreStrength,,,
CK2022_2 40-1,0.6138513680805444,,
RB2022_1_PostSprint,,,
CK2022_4 200-1,0.6299046623118946,0.46556529720801115,
JW2021_Before_2,,,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,0.6045190350136146,,
AR2021_ALG 1 μM,0.5890347393326618,0.46177898754232194,
HS2024_4_B_T1,0.5832080020552243,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,0.6098986781858085,,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,0.5881347056647337,0.49691994952901575,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,,0.49063926287953347,
CK2022_9 16-1,0.6063566901135734,,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,0.630845634197658,0.4603827854223008,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,,,
CK2022_16 16-1,0.6077966770177857,,
FS2019_db/db3,,,
CK2022_15 40-1,0.6135800582074602,,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.6242391984478716,0.4436667267546675,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,0.6025304957397103,,
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,,0.4672330939404099,
HS2024_5_PD_T3,0.573980428569422,0.4904046486434466,
AH2018_TMTMS3_3_X,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,0.6068900351492987,,
AH2018_LFQ_M_1_N,,,
KBE2022_Log2_Ex_27_U,0.60712567482398,0.4620333598604511,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,,,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,0.6237213853478405,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,,,
YA2020_Reporter_intensity_Normal_No.4,,,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,0.6086973816521448,,
RN2012_L13,0.592795309004866,,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,0.6032863330519082,,
SR2019_SKBR3_Biol_repl_3,,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,0.579711063513801,0.4592053924322888,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,0.5676589210231233,0.4728246456631751,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,0.5925404870105335,0.4416671858031795,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,0.6057378240017689,,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,0.5887543427642881,,
HH2022_Reporter intensity 6,0.6025581860285923,,
RB2022_2_RecoveryStrength,,,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,,,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,,,
AH2018_TMTMS2_3_X,,,0.2161384690412469
GF2025_P3_Adh,,0.4860586564566305,
SR2019_JIMT1_Biol_repl_2,,,
AH2018_TMTMS2_1_C,,,0.2478431908591239
RM2024_Intensity D0-1___2,,,
LY2019_P4+,0.5464614247212334,,
KBE2022_Log2_Ex_19_U,0.6068396882812898,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,0.5611197850914202,,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,,,
AST2020_Control,0.5716710344347289,,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,0.4475870829219675,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,0.597342137528679,0.41110892716386593,
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,,,
RB2022_7_RecoverySprint,0.5615484414033358,,
YA2020_Reporter_intensity_Normal_No.3,,,
HS2024_8_B_T2,0.5644808508762852,,
AH2018_LFQ_1_X,,,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,0.573625490967712,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,,0.4399321409620797,
HH2022_Reporter intensity 1,0.5633602422712494,,
HH2022_Reporter intensity 2,0.5648825312353095,,
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,,,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,0.5653128444714415,0.4790674229694783,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,
EP2017_Untreated R#2 log2 ratio,0.5834224332979672,0.4614094814744751,
SR2019_LM2_Biol_repl_3,,,
RB2022_4_RecoveryStrength,0.6332725750591102,,
CR2017_Ratio Replicate 2,0.5761379688411666,0.4388394635626713,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,0.5670834256360637,0.47096102792018985,
AR2021_KD 72h,0.5673446766096022,0.45019960722822594,
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,0.6024264430983065,0.4617877458181869,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,,,
KBE2022_Log2_Ex_9_U,0.5985602091382229,0.458174919708769,
AH2018_SILAC_M_3_N,,,
KBE2022_Log2_Ex_13_T,0.6066282382324519,,
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,,,
PG2020_Intensity Mock_10h_C,0.5533875638412936,,
CF2017_OSE 29,,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,,
HS2024_7_B_N2,0.5776659421224509,0.4675766133292741,
PG2020_Intensity 10h_A,,,
RN2012_L12,0.5683586968455325,0.49882458813980907,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,,,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,0.5654087305069068,,
FSO2013_Ratio H/M normalized Rep1___1,0.5918011336374379,0.4340088927450241,
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,0.6064130482805152,,
RB2022_7_RecoveryEndurance,0.5880415881085206,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,0.6023954449109065,,
TM2022_S2.12h.B,,,
RN2012_L15,0.5848147241822204,0.4818857011867554,
KS2014_Intensity pY_PV3,,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,,,
FSO2013_Ratio H/M normalized Rep2___2,,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,0.6089861163067231,,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,,0.46128820611227206,
RB2022_1_PreSprint,,,
HS2024_4_I_N1,0.5994567593544587,,
CK2022_7 200-1,0.6233615570857116,0.45435622699428513,
CK2022_5 200-1,0.6257988003426356,0.4560961984259881,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,0.5862261817813817,0.4480167089653189,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,,
AH2018_LFQ_2_C,,0.4423234251368892,
AH2018_SILAC_MR_1_X,,0.47374511589284457,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,0.5978685020572791,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,0.6119120947944128,,
AH2018_SILAC_3_C,,,
EJN2021_5_Rest_Ins,0.6049002827551057,,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,0.5906751827589595,0.4290067806858097,
CK2022_4 16-1,0.6070446455280958,,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,,,
EJN2021_2_Ex_Ins,0.6064079535398574,,
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,,,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,0.5478436963821691,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,,,
FSO2013_Ratio H/L normalized Rep3,0.5772395136255513,0.4805923715495202,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,0.5876090366852097,,
KBE2022_Log2_Ex_9_T,0.6054985368455635,0.4586848998499147,
AH2018_SILAC_IT_2_N,,0.4746068697025854,
AH2018_SILAC_IT_1_X,,0.4592307042321875,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,0.5958521496068869,0.4819242467607439,
UK2020_UA_2,0.5896993275903275,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,,0.46523144001310546,
WZ2023_Pe_025_20min,0.6245983167662084,0.4227826910916201,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,,,
HS2024_4_I_N2,0.5822849559717904,,
AH2018_TMTMS2_3_N,,,0.2429517321837456
RN2012_H06,0.5773132124742874,0.47991882690827264,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,0.5991033499449442,0.4877765793745728,
WZ2023_Su_005_30min,0.6247384600022879,0.43380350354221836,
SR2019_HCC1419_Biol_repl_4,,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,,,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,0.5914236616904837,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,0.5749852788409758,0.48672003849403334,
WZ2023_Su_025_10min,0.6236195911742339,0.431073091051777,
AH2018_LFQ_IT_4_X,,,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,,,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,0.6247051790391862,0.43812043838144055,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,0.5532358260813798,0.4490070577684986,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,0.5670584982401131,0.492102187413171,
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,,,
KS2014_Intensity,,0.4812710399413622,
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,,,
LY2019_P7+,,,
EP2017_Untreated R#1 normalized log2 ratio,0.5875936058930693,0.47212823468390425,
RN2012_L10,0.5693793600745573,,
PG2020_Intensity 4h_C,0.5420137115460182,,
EP2017_Mitotic R#3 normalized log2 ratio,0.5717401448165494,0.461481503744178,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,0.6088836822893399,,
RB2022_8_PostStrength,0.57769231685664,,
AH2018_SILAC_IT_2_X,,0.46009651083398495,
HS2024_4_B_T3,0.5987570450500378,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,0.5853230503604467,0.4578966591309217,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,0.5493029703572574,0.47567777823263313,
KBE2022_Log2_Ex_6_U,0.5975390658492068,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,0.5717920464033297,0.45100303425513805,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,0.6314689862723213,0.4622112699834504,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5738844453049342,0.4646565336883712,
GF2025_P9_Sph,,0.48106016341715535,
CK2022_6 200-1,0.6234415029766998,0.4552726816953763,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,,,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,,,
HS2024_4_I_T2,0.5387238948170624,0.466477555021906,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,0.6030750378745188,0.48596330035630925,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,0.5992546382866869,,
HS2024_3_B_T3,0.5512124434383228,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,,
PG2020_Intensity 2h_D,,,
EP2017_Untreated R#3 normalized log2 ratio,0.5640744952010943,0.4874805137569826,
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,0.6233801975315897,0.45519963162296234,
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,0.5745664837719623,0.46075938007238615,
RB2022_7_PostEndurance,,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5718231963266381,0.4805263508311393,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,,0.4662847526353356,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,0.5503819414507253,0.4693940457253829,
KBE2022_Log2_Ex_29_T,0.6079892629237964,0.4591395508196958,
HS2024_7_I_T2,0.6230069583350639,0.47520982491008174,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,0.5625136036932044,,
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,0.6116685003118767,,
FR2021_Intensity.M,0.573625490967712,,
RB2022_2_PostSprint,,,
AH2018_SILAC_MR_3_N,,0.4762098449588632,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,,,
PG2020_Intensity CT_C,,,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,,,
KBE2022_Log2_Ex_39_U,0.5998018975612839,,
EP2017_Untreated R#3 log2 ratio,0.5666994685822504,0.4912554597437504,
RB2022_2_PostStrength,,,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,0.5887881136951225,0.4591578766236691,
HS2024_8_PD_T2,0.590487289056011,0.46177034692892366,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,,,
FR2021_Norm.Intensity.G,0.5631603016595739,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,0.5870489504118724,0.46331998180907014,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,0.6000685769430185,,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,,,
CR2017_Ratio Replicate 2.3,0.5865055619803302,0.45604531525902275,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,,0.4906096232732083,
YA2020_Reporter_intensity_Normal_No.2,,,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,0.5844572648623114,0.4678223265085693,
HS2024_3_PD_T3,0.5693930340333544,,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,0.5663460876350113,,
RAM2015_Log2 C,,,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,0.6069403386707147,,
CK2022_2 16-1,0.606837542815187,,
RAM2015_Log2 B,0.5806965928456742,,
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,0.6035854884611317,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,0.5584367462167694,,
UK2020_HCM_5,0.589926293952405,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,,
HS2024_7_PD_T3,0.5858653773762625,0.4718720021692704,
PG2020_Intensity Mock_10h_B,0.5612219785184209,,
WZ2023_Su_025_30min,0.6242730377702268,0.41619974061687187,
AH2018_LFQ_4_N,,,
CR2017_Ratio Replicate 1.2,0.5633245534722015,0.4038521606057895,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,,,
HS2024_8_I_N1,0.5804110861955349,0.48932423435801714,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,0.6071910570525293,,
AH2018_SILAC_M_1_X,,,
RB2022_7_PreEndurance,0.5594730315539403,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,,
LY2019_P6+,,,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,,0.46456080022901897,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,0.5534178047980818,0.4723149089180709,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,,,
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,,,
KS2014_Intensity C5,,0.47393065153851577,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,
GF2025_P9_Adh,,0.47437514997358043,
RB2022_3_PostStrength,,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,0.5828171806365366,,
SR2019_BT549_Biol_repl_1,,,
AH2018_LFQ_M_4_N,,,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,,,
AH2018_LFQ_2_X,,0.4505099112198423,
PG2020_Intensity 2h_B,0.5523815114880548,,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,,,
KS2014_Intensity E15_3,,0.4639028505485115,
GF2025_P3_Sph,,0.4942352821440801,
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,,,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.4540558956201754,
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,,0.47461806835536463,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,,,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,0.5817019014856384,0.48663282145885206,
ZQ2022_N1,,,
LY2019_P6-,,,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,0.5911994286090666,,
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,0.5789152242054724,0.47503024043542585,
AH2018_LFQ_3_N,,,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,0.5457091614137362,,
UK2020_UA_1,0.5907294058646391,,
KBE2022_Log2_Ex_13_U,0.6018906916940422,,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,
RB2022_1_RecoverySprint,0.6069065145351632,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,0.6064505735303282,,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,,,
SR2019_BT549_Biol_repl_2,,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,,,
HS2024_5_PD_T2,0.5911581011016491,0.47845267135312347,
WZ2023_Su_025_20min,0.6213042017346159,0.43417568399980944,
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,0.5962118081156321,,
LY2019_P8-,,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,0.5901625208304322,0.41358896618340824,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,0.6135316083087798,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,0.5844310537506854,,
PG2020_Intensity 10h_D,,,
RB2022_8_PreEndurance,,,
HS2024_3_B_N2,0.5646172274601831,,
EJN2021_4_Ex_Ins,0.6035069595167301,,
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,0.6117833521070979,,
EP2017_Pervanadate R#3 log2 ratio,0.5689401848977227,0.48292964467884647,
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,,,
AH2018_SILAC_MR_3_C,,0.4762993976243997,
AH2018_LFQ_M_4_C,,,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,0.572741530062449,,
CK2022_6 40-1,0.6068649226261126,,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,0.6050669986238105,,
LY2019_P3-,0.6051994466994923,,
FR2021_Intensity.A,0.5621941594109084,,
EJN2021_3_Ex_Ins,0.6064795578958085,,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.6252034290749604,0.4326250334775655,
HS2024_8_PD_T3,0.5947167068630004,0.4737447052700207,
EJN2021_3_Ex_Basal,0.6062926801439602,,
AST2020_Control.1,0.5753597621618107,,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,,,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,0.6254234880641262,0.4368837942118782,
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,,0.4753009645273414,
RB2022_1_RecoveryStrength,0.626846885900053,,
SR2019_HCC1954_Biol_repl_4,,,
FR2021_Norm.Intensity.N,0.5527761863480223,,
HS2024_5_B_N1,0.5986326592417731,0.46278975644037484,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,,,0.2679754723221136
RB2022_4_PreSprint,,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,,,
HS2024_8_I_N2,0.5771621038225215,0.48327649372028825,
RB2022_3_RecoveryStrength,0.5820627402448302,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,,,
LY2019_P8+,,,
RB2022_2_RecoveryEndurance,,,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,0.5817889074587563,,
KS2014_Intensity pY_PV1,,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.4567424843271997,
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,,,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,0.6011325610712518,,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,,,
LY2019_P2-,0.5577245607057753,,
AH2018_LFQ_IT_1_X,,,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,0.6209159471399675,,
WZ2023_Pe_005_20min,0.6241003570541614,0.4259558371878405,
AST2020_Control.2,0.569477284346912,,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,0.5669000679371726,0.4751544962630123,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,0.6143443707024092,,
SR2019_MCF10A_Biol_repl_4,,,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,,,
HS2024_5_B_T2,0.5953061471205501,,
HS2024_6_I_T1,0.5914056845696344,0.47503023680948403,
HS2024_5_B_T3,0.586462490709089,0.4704816933026788,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,0.6005675156552059,0.46581872134096175,
AH2018_TMTMS3_3_N,,,
SR2019_HCC1419_Biol_repl_2,,,
FR2021_Intensity.N,0.5527188836622392,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,,0.44341629428961227,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,0.5727501904405441,0.4635044590588286,
KBE2022_Log2_Ex_36_T,0.6113127184916454,0.4626048570630621,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.6238722812462049,0.44348793444478946,
KS2014_Intensity C2,,0.46040199167224993,
FSO2013_Ratio H/L normalized Rep1___2,,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,0.6081154727034553,,
CK2022_9 200-1,0.6301586039920218,0.4727759667850761,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,0.6289033166024073,0.4725740812617641,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,0.5326471860696591,,
RBK2021_1332T Late,,,
LY2019_P1-,0.5639800083149469,,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,0.5883368339826703,0.48051395885096126,
HS2024_3_I_T3,0.5888169548488409,0.45241043169791123,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,,0.4574065608465887,
ZQ2022_C3,,,
EJN2021_3_Rest_Ins,0.6065378576019022,,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,0.6051337920608254,,
FSO2013_Ratio H/M normalized Rep3___2,,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,0.5901921690791966,0.4755527793517283,
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,0.6229980602131021,0.44412816429600194,
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,,,
HS2024_5_I_T3,0.5629902335261874,0.45258325133549393,
KS2014_Intensity N1,,0.43499811336557315,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,0.5682590593857285,0.4733897223238075,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,,0.4742962555877383,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,,0.4754165217689792,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,0.5874159166088242,0.49830601363687377,
HS2024_5_B_N2,0.572586734068542,0.4778543753534752,
HS2024_5_I_N1,0.5750269272415136,0.48068323067468227,
HS2024_6_I_N1,0.5637325059844243,,
AR2021_KD 48h,0.5756511758636709,0.44223536910517947,
FR2021_Intensity.B,0.5575597817834004,,
RB2022_3_PreEndurance,,,
HS2024_5_I_T1,0.5777621846279072,0.47450398589247306,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,0.583336705066127,,
SR2019_MDAMB231_Biol_repl_1,,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.6253528817703441,0.42713536850503253,
KBE2022_Log2_Ex_29_U,0.6110211056129378,0.45753160235636986,
HS2024_7_B_T1,0.569018131533737,,
AH2018_LFQ_M_2_X,,0.4585905747033456,
AH2018_LFQ_IT_4_N,,,
CK2022_15 200-1,0.6316727061809986,0.46037995279446026,
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,0.6132719747003179,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,0.5851796187878378,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,0.6312310792761409,0.46671785845212294,
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.6232487249266877,0.4307769447891088,
RN2012_H01,0.5781359079491432,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,0.6067110606062851,,
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.567591887269781,0.4927420376026536,
HS2024_8_B_T3,0.5557829758656071,0.46921795609778855,
YA2020_Reporter_intensity_Cancer_No.3,,,
KBE2022_Log2_Ex_44_U,0.6058056850634488,,
WZ2023_Pe_010_20min,0.6248718216446479,0.424883612040647,
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,0.5495932467983906,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,0.47576556037559836,
RCJD2014_10min_mean,,,
KS2014_Intensity C1,,0.4771742044068899,
FSO2013_Ratio H/M normalized Rep3___1,0.5673371866450413,0.471248940902917,
AH2018_SILAC_M_3_C,,,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,,0.4670778663569301,
AH2018_SILAC_M_2_X,,0.4663987636985729,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,0.6055294996877298,,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.623041708497394,0.4382818568295869,
PG2020_Intensity 6h_C,,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,,0.4438591814935077,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,,,0.2498166246483716
CK2022_15 16-1,0.6087220347595729,,
CK2022_3 16-1,0.60781067045426,,
LY2019_P4-,0.5524966843531812,,
FSO2013_Ratio H/L normalized Rep3___2,,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,0.5531585723826209,,
GF2025_P8_Adh,,0.47856670916144056,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,,0.4885213546928448,
CK2022_10 16-1,0.6072817145018792,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.4530510777399799,
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,0.5892416397187132,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,0.596161330284188,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,0.5740321058198348,0.4651979474982566,
EJN2021_2_Ex_Basal,0.6081564669243504,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,,,
AR2021_L41 10 μM,0.5658144606085399,0.44714321933322426,
CF2017_EOC 2,,,
RB2022_6_PostEndurance,,,
AH2018_SILAC_1_N,,,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,0.5884829465026645,,
RB2022_7_PreSprint,0.5654546084464154,,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,0.5795206698120323,,
CK2022_6 16-1,0.6038730048251071,,
ZX2022_CB treated Replicate 1,0.5840143235547567,0.4588124002536276,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,0.5646939223628028,,
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,,,0.3033628212775034
AR2021_L41 1 μM,0.565591913260665,0.46423509307667493,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,,,0.2899813765803962
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,0.5871859948721241,0.4576887320429907,
KS2014_Intensity C4,,0.4729679409183234,
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,0.6041357922838364,0.45811646705236325,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,0.5550146776960455,,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,,,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,,,
AH2018_SILAC_IT_3_C,,0.476421909392362,
WZ2023_Pu_025_10min,0.6239257414251208,0.4221059484238973,
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,0.583291224486854,0.4888208154214193,
SR2019_JIMT1_Biol_repl_4,,,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,,,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,0.6232793531984611,0.40803041935632445,
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,,0.47033276687735404,
KS2014_Intensity C6,,0.46455052949406334,
ZQ2022_N3,,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,0.6132673130796616,,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,0.5896511082996965,0.4603888995520508,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,0.6146398569861447,,
AH2018_SILAC_IT_2_C,,0.4764105558446647,
CK2022_5 40-1,0.6090242830910728,,
AH2018_LFQ_3_X,,0.4285803459901307,
UK2020_UA_3,0.5887429881136508,,
LY2019_P7-,,,
GF2025_P5_Adh,,0.49096851045743245,
RB2022_1_PostStrength,0.6019967403954465,,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,0.5775365586160915,0.48093014294233544,
SR2019_HCC1954_Biol_repl_3,,,
CR2017_Ratio Replicate 2.2,0.5859421559156355,0.41647530456238796,
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,0.6074782827592864,,
ZQ2022_C1,,,
CR2017_Ratio Replicate 2.1,0.5838188556653512,0.47411792623266663,
PG2020_Intensity CT_B,,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,,0.47588831268510684,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,0.4603681625782093,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,,,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,,0.4413436706519022,
YA2020_Reporter_intensity_Cancer_No.4,,,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,,0.4949584165927168,
RB2022_2_PreEndurance,,,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,0.6014712264592662,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,0.5776937396567501,,
CK2022_14 16-1,0.6081831793900232,,
AST2020_anti-CD3+PDL2,0.5723363147711739,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,0.6061284426359965,,
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,,,
FSO2013_Ratio H/M normalized Rep1___2,,,
HS2024_8_I_T1,0.5315637354759685,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,0.4772980104371635,
EP2017_Mitotic R#2 log2 ratio,0.5703518253240973,0.4697482470289844,
AH2018_TMTMS2_1_X,,,0.2584518693695746
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,0.5995953315585497,,
HS2024_6_I_N2,0.5709957846050766,,
HH2022_Reporter intensity 4,0.5953281535249519,,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,,,
HS2024_4_I_T3,0.5884319191643576,0.4982632059399082,
AH2018_SILAC_1_X,,,
PG2020_Intensity 10h_B,,,
AH2018_TMTMS3_1_X,,,
CF2017_FTE 14,,,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,,,
SR2019_HCC1419_Biol_repl_3,,,
KBE2022_Log2_Ex_14_T,0.6021572531730764,,
EP2017_Untreated R#2 normalized log2 ratio,0.5810535464059933,0.4591896060199218,
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,,,
HS2024_5_I_N2,0.5868125403901405,0.4921589663762349,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,0.571105535741246,0.480099512751869,
AS2011_Ratio H/L Normalized RNAi_2_1,,,
